|
ARHGAP17 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
8.58719999996538E-07 |
| Normal-vs-Stage3 |
1.62436730732907E-12 |
| Normal-vs-Stage4 |
5.40678612992451E-14 |
| Stage1-vs-Stage2 |
2.203100E-03 |
| Stage1-vs-Stage3 |
6.015600E-02 |
| Stage1-vs-Stage4 |
7.422900E-04 |
| Stage2-vs-Stage3 |
1.131960E-01 |
| Stage2-vs-Stage4 |
6.219800E-01 |
| Stage3-vs-Stage4 |
1.841580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.30370048090356E-10 |
| Normal-vs-Asian |
5.822800E-03 |
| Caucasian-vs-AfricanAmerican |
7.676400E-01 |
| Caucasian-vs-Asian |
1.502250E-01 |
| AfricanAmerican-vs-Asian |
1.592970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
4.976800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.89009999996115E-07 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
6.049400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.966800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.186800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.858200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.516200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.270000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.292800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.74710000000466E-06 |
| Normal-vs-Grade 2 |
1.62447832963153E-12 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.80855330711438E-12 |
| Grade 1-vs-Grade 2 |
1.421960E-02 |
| Grade 1-vs-Grade 3 |
1.46789999999619E-06 |
| Grade 1-vs-Grade 4 |
6.371000E-04 |
| Grade 2-vs-Grade 3 |
7.81870000000628E-05 |
| Grade 2-vs-Grade 4 |
3.267600E-02 |
| Grade 3-vs-Grade 4 |
6.254600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
1.62447832963153E-12 |
| ccA subtype-vs-ccB subtype |
1.997760E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
8.178600E-04 |
| N0-vs-N1 |
2.622600E-01 |
|
|
